Latest News about NBIX
Recent news which mentions NBIX
US Stocks Mixed; JM Smucker Slashes Annual Guidance
August 28, 2024
From Benzinga
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
August 27, 2024
From Benzinga
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
From Benzinga
From InvestorPlace
Tickers
NBIX
From InvestorPlace
3 Red-Hot Biotech Rockets Blasting Off in 2024
April 24, 2024
From InvestorPlace
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
April 23, 2024
From Benzinga
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
March 19, 2024
From Benzinga
From InvestorPlace
From Benzinga
Breaking Down Neurocrine Biosciences: 8 Analysts Share Their Views
February 08, 2024
Tickers
NBIX
From Benzinga
Earnings Scheduled For February 7, 2024
February 07, 2024
From Benzinga
From InvestorPlace
3 Stocks at the Forefront of Medical Innovation
December 25, 2023
From InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in December
December 15, 2023
From InvestorPlace
Analyst Expectations for Neurocrine Biosciences's Future
December 07, 2023
Tickers
NBIX
From Benzinga
Why Is Neurocrine Biosciences Stock Trading Lower Today?
November 10, 2023
From Benzinga
Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say
November 10, 2023
From MarketWatch
3 Biotech Moonshots to Bet on the Future of Health
November 06, 2023
From InvestorPlace
Raymond James Maintains Outperform Rating for Neurocrine Biosciences: Here's What You Need To Know
November 01, 2023
Tickers
NBIX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
